The recent FDA marketing authorization for six on! PLUS nicotine pouch products puts Altria Group (MO) back in focus, as ...

If there's not a great degree of confidence in its future, then it may not matter a great deal that Altria's payout ratio is ...

In late 2025, the FDA granted marketing authorization for six on! PLUS nicotine pouch products made by Altria Group’s Helix ...

Altria's business has hit a worrying inflection point, which could lead to a very troubling situation in five years' time.

Altria Group Inc. urged a Virginia federal judge to immediately shut down a probe seeking to block imports of its NJoy units’ ...

Altria (MO) offers a contrarian buy setup: near $55 support with rebound signals, plus ~10x P/E and strong profitability for ...

Altria's strong dividend payments helped its stock beat the S&P 500's total return over the last five years. The tobacco giant has avenues to outperform the S&P 500 again over the next five years.

Altria Group, Inc. presents compelling turnaround opportunity for 2026, driven by leadership transition & regulatory wins.

Stodgy tobacco stock Altria Group (NYSE: MO), most known for selling Marlboro cigarettes in the U.S. and paying hefty dividends to its shareholders, has sprung to life this year. The stock has ...

Tortoise-like tobacco giant Altria Group (NYSE: MO) has been uncharacteristically hot this year. Shares are up over 15% in 2024, an uncommon surge given the stock's poor share price performance over ...

On the surface, the tobacco giant looks too tempting to ignore. However, some tantalizing metrics may belie reasons for long-term concern. Investors must examine Altria’s dividend sustainability. 10 ...

Juul Labs Inc. asked an Arizona federal judge to bar Altria Group Inc. and its NJoy units from using documents Juul says were ...